Skip to product information
1 of 1

Ambossle

Continuing Education Company 10th Annual Diabetes, Obesity, & Metabolic Disease Conference 2025

Continuing Education Company 10th Annual Diabetes, Obesity, & Metabolic Disease Conference 2025

Regular price $80.00 USD
Regular price $90.00 USD Sale price $80.00 USD
Sale Sold out

we'll contact you for payment after receiving your order

Continuing Education Company 10th Annual Diabetes, Obesity, & Metabolic Disease Conference 2025

Target Audience: primary care clinicians, family medicine providers, and internal medicine professionals

Information:

Hosted at the Westin San Diego Gaslamp Quarter, San Diego, CA from April 25–27, 2025, this flagship event offers in-person attendance or live webcast participation. Designed specifically for primary care providers, it delivers the latest updates and practical strategies in managing patients with metabolic illness.


What You’ll Gain

  • Comprehensive clinical sessions on diabetes management, obesity interventions, MASLD/MASH (fatty liver disease), heart failure with preserved ejection fraction, and novel therapeutics

  • Evidence-based deep dives into lifestyle medicine approaches, pharmacotherapy innovations, and comorbidity treatment strategies

  • Interactive case reviews and expert Q&A formats to reinforce real-world application and decision-making

  • Flexible access including live attendance and on-demand replay for up to 90 days post-conference


Who Should Attend

  • Family medicine physicians, internists, and primary care providers managing metabolic and endocrine conditions

  • Physician assistants, nurse practitioners, pharmacists, and diabetes care teams focused on chronic disease coordination

  • Medical residents and internal medicine trainees seeking practical updates before board exams or clinical rotations

  • Health system educators and clinic leaders developing protocols and structured training in metabolic disease care


Why This Conference Stands Out

  • Tailored by primary care–focused CME experts to address real-world metabolic disease challenges

  • Balanced agenda combining high-yield clinical science and case-based learning in half-day formats

  • Destination venue in San Diego allows a blend of professional development and leisure

  • Live streaming option ensures flexibility for participants unable to travel


Advance Your Metabolic Disease Practice

Attend the 10th Annual Diabetes, Obesity & Metabolic Disease Conference 2025 to update your clinical toolkit, apply cutting-edge therapies, and elevate patient outcomes in chronic metabolic care.

▶️ Register today to reserve your spot or access the live webcast—and make full use of post-event replay access.

 

 Topics:

On Demand Replay: FRIDAY, April 25, 2025
DAY 1 – Diabetes and Cardio-Renal Disease Management with Cases
M. McDonnell, MD Treating Obesity to Treat Diabetes: Cutting the Gordian Knot
N. Desai, MD The Cardiovascular-Kidney-Metabolic Syndrome: Timely Identification, Optimal Management, and Lingering Questions
M. McDonnell, MD Highlights from the 2025 ADA Standards of Care: Drug Selection, Technology and Nutrition
N. Desai, MD Identifying and Treating HFpEF: It’s All About the Phenotype…
M. McDonnell, MD & N. Desai, MD Cases in Diabetes, Renal and Cardio-Kidney Metabolic Disease
On Demand Replay: SATURDAY, April 26, 2025
DAY 2 – Comprehensive Obesity Management and MASLD/MASH with Case Studies
L. Kaplan, MD The Biology of Obesity and its Implications for Effective Treatment
D. Thiara, MD Beyond the Scale: Harnessing Anti-Obesity Medications to Treat Obesity and its Complications
D. Thiara, MD Midlife Metamorphosis in Women: Tackling Obesity During Aging and Menopause
L. Kaplan, MD Strategies for Optimizing Outcomes of Obesity Treatment
L. Kaplan, MD & D. Thiara, MD Cases in Obesity Management
M. Rinella, MD Diagnosis and Management of MASLD/MASH
M. Rinella, MD Cases in the Diagnosis and Management of MASLD/MASH
On Demand Replay: SUNDAY, April 27, 2025
DAY 3 – Hypertension and Dyslipidemia Management with Case Studies
J. Basile, MD (Chairperson) Update on Secondary Causes of Hypertension
C. Ballantyne, MD Treatment of LDL-C, Non-HDL-C and Apo B-Statins and Beyond
C. Ballantyne, MD Triglycerides and Lp(a): Where Are We Now and Where Are We Going?
J. Basile, MD & C. Ballantyne, MD Cases in Hypertension and Dyslipidemia
View full details